ACST: Acasti Company Aggregate Debts

Acasti Pharma specializes in developing therapies for rare cardiac and neurological disorders. This chart of the individual debt value reflects a level of 0.00. Acasti Pharma is developing partnerships with research centers to conduct clinical trials. The business targets the non-opioid pain relief market for individuals with chronic pain. Meanwhile, research and development capacities are functioning seamlessly, ensuring equipment is in ideal condition.

This indicator measures total leverage, allowing for the separation of short-term accounting operations from the long-term trend of financial stability. An analysis of total debt helps assess the extent to which Acasti Pharma (ACST) investments in sustainable reagent disposal and research ethics burden the balance sheet, determining the final equilibrium between issuer reliability and the pace of business development.